| __timestamp | AbbVie Inc. | PTC Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 3297000000 | 79838000 |
| Thursday, January 1, 2015 | 4285000000 | 121816000 |
| Friday, January 1, 2016 | 4366000000 | 117633000 |
| Sunday, January 1, 2017 | 4982000000 | 117456000 |
| Monday, January 1, 2018 | 10329000000 | 171984000 |
| Tuesday, January 1, 2019 | 6407000000 | 257452000 |
| Wednesday, January 1, 2020 | 6557000000 | 477643000 |
| Friday, January 1, 2021 | 7084000000 | 540684000 |
| Saturday, January 1, 2022 | 6510000000 | 651496000 |
| Sunday, January 1, 2023 | 8453000000 | 666563000 |
| Monday, January 1, 2024 | 12791000000 |
In pursuit of knowledge
In the ever-evolving world of biotechnology, research and development (R&D) is the lifeblood of innovation. Over the past decade, AbbVie Inc. and PTC Therapeutics, Inc. have demonstrated contrasting strategies in their R&D investments. From 2014 to 2023, AbbVie consistently allocated substantial resources, with a peak in 2018 when R&D expenses surged by over 100% compared to 2014. This commitment underscores AbbVie's focus on expanding its therapeutic portfolio.
Conversely, PTC Therapeutics, Inc. has shown a steady increase in R&D spending, growing by approximately 735% over the same period. This growth reflects PTC's dedication to pioneering treatments for rare disorders. By 2023, PTC's R&D expenses reached nearly 667 million, a testament to its strategic focus on innovation. These insights reveal how both companies are shaping the future of healthcare through their unique R&D approaches.
Comparing Innovation Spending: Novo Nordisk A/S and AbbVie Inc.
AbbVie Inc. or Gilead Sciences, Inc.: Who Invests More in Innovation?
Comparing Innovation Spending: AbbVie Inc. and Veracyte, Inc.
AbbVie Inc. vs Viridian Therapeutics, Inc.: Strategic Focus on R&D Spending
GSK plc vs PTC Therapeutics, Inc.: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for Bio-Techne Corporation and PTC Therapeutics, Inc.
R&D Insights: How Sarepta Therapeutics, Inc. and PTC Therapeutics, Inc. Allocate Funds
Research and Development Investment: Halozyme Therapeutics, Inc. vs PTC Therapeutics, Inc.
Research and Development: Comparing Key Metrics for ADMA Biologics, Inc. and PTC Therapeutics, Inc.
Viking Therapeutics, Inc. vs PTC Therapeutics, Inc.: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for PTC Therapeutics, Inc. and Perrigo Company plc
Who Prioritizes Innovation? R&D Spending Compared for PTC Therapeutics, Inc. and Ligand Pharmaceuticals Incorporated